NICE recommends new treatment option for people with blood and lymphatic cancers
Hundreds of people are set to benefit as NICE recommends acalabrutinib for newly diagnosed mantle cell lymphoma and chronic lymphocytic leukaemia Mantle cell lymphoma MCL is a rare and aggressive…
500,000 eligible to benefit from new non-hormonal treatment for hot flushes caused by menopause
A new treatment option for menopausal hot flushes and night sweats can be used in the NHS when hormone replacement therapy (HRT) is not suitable Fezolinetant (Veoza*) is recommended to…